Relationship between plasma leptin levels and the tumor necrosis factor-α system in obese subjects

International Journal of Obesity

Volumn 23, Issue 4, 1999, Pages 355-360

  Corica, Francesco ^a,c   Allegra, A ^a   Corsonello, A ^a   Buemi, M ^a   Calapai, G ^b   Ruello, A ^a   Nicita Mauro, V ^a   Ceruso, D ^a  

^a Department of Internal Medicine   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c Salita Villa Contino   (Italy)

Author keywords

Leptin; Obesity; TNF receptors; TNF

Indexed keywords

INSULIN; LEPTIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ANTHROPOMETRY; ARTICLE; BIOASSAY; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HIP; HOMEOSTASIS; HUMAN; HUMAN CELL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; MULTIVARIATE ANALYSIS; OBESITY; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0032963307     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800826     Document Type: Article

References (49)

1. 1 Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse ob gene and its human homologue. Nature 1994; 372: 425-432.
2. 2 Frederich RC, Hamann A, Anderson S, Loliman B, Lowell BB, Flier JS. Leptin reflects body lipid content in mice: evidence for diet-induced leptin resistance. Nat Med 1995; 1: 1311-1314.
3. 3 Spiegelman BM, Flier JS. Adipogenesis and obesity. Rounding out the big picture. Cell 1996; 87: 377-389.
4. 4 Rink TJ. In search of a satiety factor. Nature 1995; 372: 406-407.
5. 5 Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV. Leptin: the tale of an obesity gene. Diabetes 1996; 45: 1455-1462.
6. 6 Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse ob protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546-548.
7. 7 Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-546.
8. 8 Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-543.
9. 9 Weigle DS, Bukowski TR, Foster DC, Holderman S, Kramer JM, Lasser G, Lofton-Day CE, Prunkard DE, Raymond C, Kuijper JL. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J Clin Invest 1995; 96: 2065-2070.
10. 10 Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91.
11. 11 Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Imsolo RB. The expression of tumor necrosis factor in human adipose tissue: regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995; 95: 2111-2119.
12. 12 Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor alpha in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-2415.
13. 13 Hotamisligil GS, Budavari A, Murray D, Spiegelman BM. Reduced tyrosine activity of the insulin receptor in obesity-diabetes: central role of tumor necrosis factor-α. J Clin Invest 1994; 94: 1543-1549.
14. 14 Toomey D, Redmond P, Bouchier-Hayes D. Mechanisms mediating cancer cachexia. Cancer 1995; 76: 2418-2426.
15. 15 Staal van den Brekel AJ, Dentener MA, Schols AM, Buurman WA, Wouters EF. Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J Clin Oncol 1995; 13: 2600-2605.
16. 16 Tracey KJ, Cerami A. Tumor necrosis factor and regulation of metabolism in infection: role of systemic versus tissue levels. Proc Soc Exp Biol Med 1992; 200: 233-239.
17. 17 Keller U. Pathophysiology of cancer cachexia. Support Care Cancer 1993; 1: 290-294.
18. 18 Sarraf P, Frederich RC, Turner EM, Ma G, Jaskowiak NT, Rivet DJ 3rd, Flier JS, Lowell BB, Fraker DL, Alexander HR. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med 1997; 185: 171-175.
19. 19 Kirchgessner TG, Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Tumor necrosis factor α contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest 1997; 100: 2777-2782.
20. 20 Zumbach MS, Boehme MWJ, Wahl P, Stremmel W, Ziegler R, Nawroth PP. Tumor Necrosis Factor increases serum leptin levels in humans. J Clin Endocrinol Metab 1997; 82: 4080-4082.
21. 21 Mantzoros CS, Moschos S, Avramopoulos I, Kaklamani V, Liolios A, Doulgerakis DE, Griveas I, Katsilambros N, Flier JS. Leptin concentrations in relation to body mass index and the tumor necrosis factor-α system in humans. J Clin Endocrinol Metab 1997; 82: 3408-3413.
22. 22 Hotamisligil GS, Arner P, Atkinson RL, Spiegelman BM: Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes 1997; 46: 451-455.
23. 2) as a measure of fatness. Int J Obes 1991; 15: 295-302.
24. 24 World Health Organisation. Measuring obesity - classification and description of anthropometric data. WHO Regional Office for Europe, Nutrition Unit. # EUR/ICP/NUT 125: Copenhagen, 1988.
25. 25 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
26. 26 Haffner SM, Gonzalez C, Miettinen H, Kennedy E, Stern MP. A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care 1996; 19: 1138-1141.
27. 27 Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E, Pan A, Garvey WT. The metabolic significance of leptin in humans: gender based differences in relationship to adiposity, insulin sensitivity and energy expenditure. J Clin Endocrinol Metab 1997; 82: 1293-1300.
28. 28 Considine RV, Sinha MK, Heiman ML, Kriausiunas A, Stevens TW, Nyce MR, Ohannessian JP, Marco CC, McKee LJ, Baur TL, Caro JF. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-295.
29. 29 Choy LN, Rosen BS, Spiegelman BM. Adipsin and an endogenous pathway of complement from adipose cell. J Biol Chem 1992; 267: 12736-12741.
30. 30 Socher SH, Friedman A, Martinez D. Recombinant human tumor necrosis factor induces acute reductions in food intake and body weight in mice. J Exp Med 1988; 167: 1957-1962.
31. 31 Michie HR, Sherman ML, Spriggs OR, Rounds J, Christie M, Wilmore DW. Chronic TNF infusion causes anorexia but not accelerated nitrogen loss. Ann Surg 1989; 209: 19-24.
32. 32 Grunfeld C, Zhao C, Fuller J, Pollock A, Moser A, Friedman J, Feingold KR. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. A role for leptin in the anorexia of infection. J Clin Invest 1996; 97: 2152-2157.
33. 33 Bemelmans MHA, van Tis LJH, Buurman WA. Tumor Necrosis Factor: function, release and clearance. Crit Rev Immunol 1996; 16: 1-11.
34. 34 Samsonov MY, Tilz GP, Egorova O, Reibnegger G, Balabanova RM, Nassonov EL, Nassonova VA, Wachter H, Fuchs D. Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus. Lupus 1995; 4: 29-32.
35. 35 Niskanen LK, Haffner S, Karhunen LJ, Turpeinen AK, Miettinen H, Uusitupa MI. Serum leptin in obesity is related to gender and body fat topography but does not predict successful weight loss. Eur J Endocrinol 1997; 137: 61-67.
36. 36 Bennett FI, McFarlane-Anderson N, Wilks R, Luke A, Cooper RS, Forrester TE. Leptin concentration in women is influenced by regional distribution of adipose tissue. Am J Clin Nutr 1997; 66: 1340-1344.
37. 37 Shimizu H, Shimomura Y, Hayashi R, Ohtani K, Sato N, Futawari T, Mori M. Serum leptin concentration is associated with total body fat mass, but not abdominal fat distribution. Int J Obes 1997; 21: 536-541.
38. 38 Haffner SM, Stern MP, Miettinen H, Wei M, Gingerich RL. Leptin concentrations in diabetic and nondiabetic Mexican-Americans. Diabetes 1996; 45: 822-824.
39. 39 Rosenbaum M, Nicolson M, Hirsch J, Heymsfield SB, Gallagher D, Chu F, Leibel RL. Effects of gender, body composition and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 1996; 81: 3424-3427.
40. 40 Segal KR, Landt M, Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 1996; 45: 988-991.
41. 41 Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA. The expression of TNFα by human muscle: relationship to insulin resistance. J Clin Invest 1996; 97: 1111-1116.
42. 42 Haffner SM, Miettinen H, Mykkänen L, Karhapää P, Rainwater DL, Laasko M. Leptin concentrations and insulin sensitivity in normoglycemic men. Int J Obes 1997; 21: 393-399.
43. 43 Fernandez-Real JM, Gutierrez C, Ricart W, Casamitjana R, Fernandez-Castaner M, Vendrell J, Richart C, Soler J. The TNF-α gene NCo I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes 1997; 46: 1468-1472.
44. 44 Hotamisligil GS, Spiegelman BM. TNF alpha and the insulin resistance of obesity. In: LeRoith D, Taylor SI, Olefsky JM (eds). Diabetes Mellitus, a fundamental and clinical test. Lippincott-Raven: Philadelphia, 1996, 554-560.
45. 45 Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A. Tumor necrosis factor-α suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 1993; 268: 26055-26058.
46. 46 Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1 mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α and obesity-induced insulin resistance. Science 1996; 271: 665-668.
47. 47 Peraldi P, Hotamisligil GS, Buurman WA, White MF, Spiegelman BM. Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J Biol Chem 1996; 271: 13018-13022.
48. 48 Liu LS, Spelleken M, Rohrig K, Hauner H, Eckel J. Tumor necrosis factor-α acutely inhibits insulin signalling in human adipocytes. Implication of the p80 tumor necrosis factor receptor. Diabetes 1998; 47: 515-522.
49. 49 Eckel RH. Insulin resistance: an adaptation for weight maintenance. Lancet 1992; 340: 1452-1453.